Endothelin suppresses donor-cell H3K9me3 and increases H3K4me3, improving SCNT efficiency and pluripotent stem cell induction.
Targeted inhibition of miR-210-3p and miR-155-5p reduces senescence and restores alveolar cell trans-differentiation for lung regeneration.
Proteases and perfluorocarbons in the collection solution prevent apoptosis and necrosis, increasing viable stem cell yield.
PDE4 inhibitors and forskolin expand primordial germ cells by elevating intracellular cAMP levels, removing the need for somatic cell support.
Defined growth factor formulation resolves batch variation in serum-free media while maintaining rapid proliferation and undifferentiated state.
Defined serum-free media containing ErbB3 ligands enable large-scale production of uniform stem cell aggregates while maintaining genetic stability.
Inhibiting Dot1L, YY1, and SUV39H1 enzymes reduces oncogene upregulation risk during induced pluripotent stem cell production.